4.5 Article

Male patients' preferences for opioid use treatment programs

Related references

Note: Only part of the references are listed.
Article Psychology, Clinical

A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations

Jawad M. Husain et al.

Summary: Clinical guidelines recommend opioid agonist treatment (OAT) as the first-line treatment for opioid use disorder (OUD). However, racial/ethnic minoritized patients are less likely to receive OAT compared to non-Hispanic White patients. Understanding the barriers and perceptions of OAT across different racial/ethnic groups is crucial for addressing these disparities.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2023)

Article Health Care Sciences & Services

Identifying the most common barriers to opioid agonist treatment in an Australian setting

Natasha Yvonne Hall et al.

Summary: This paper aimed to determine the most important barriers to OAT for Australian clients. The study found that stigma, lack of support services, inflexibility, and enjoyment of opioid use were the most important barriers. Additionally, certain groups such as females/non-binary individuals, non-users of OAT, younger individuals, and those with high dependence scores were more impacted by these barriers.

AUSTRALIAN JOURNAL OF PRIMARY HEALTH (2023)

Article Substance Abuse

I'm Clean and Sober, But Not Necessarily Free: Perceptions of Buprenorphine Among Patients in Long-Term Treatment

Jessica J. Wyse et al.

Summary: Despite recognizing the benefits of long-term buprenorphine treatment, many patients express a desire to discontinue. Their motivations to discontinue treatment fall into four categories: perceived side effects, unhappiness with dependence, stigmatized beliefs, and fears of unknown effects.

SUBSTANCE ABUSE (2023)

Article Substance Abuse

I wanted something that was more flexible: A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program

Laura Checkley et al.

Summary: The study found that patients in an urban hospital-based opioid treatment program chose buprenorphine over methadone primarily due to increased flexibility, decreased sedation, and greater effectiveness in preventing opioid use. However, some patients also encountered challenges during the transition to buprenorphine.

SUBSTANCE ABUSE (2022)

Article Psychology, Clinical

Treatment preference for opioid use disorder among people who are incarcerated

Eliana Kaplowitz et al.

Summary: This study conducted 40 semi-structured qualitative interviews with individuals receiving MOUD incarcerated at the Rhode Island Department of Corrections. The results indicate that people who are incarcerated have preferences for certain types of MOUD, which are influenced by medication side effects, route of administration, delivery in the community, and stigma.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Article Psychology, Clinical

?Sick and tired of being sick and tired?: Exploring initiation of medications for opioid use disorder among people experiencing homelessness

Natalie Swartz et al.

Summary: Individual factors such as belief in the effectiveness of MOUD, peer influence, and family influence all impact initiation of MOUD among homeless individuals. Social factors play a role in encouraging or deterring MOUD initiation. Structural factors, such as barriers within health and treatment systems, hinder access to MOUD.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Article Substance Abuse

Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder

Sandeep M. Nayak et al.

Summary: This study found that family members have relatively low familiarity and approval of MOUD treatments, with a common desire for family members to never use opioids. There is a need for healthcare providers and researchers to engage with family members to understand their preferences and attitudes towards treatment, and how this may impact patient engagement.

DRUG AND ALCOHOL DEPENDENCE (2021)

Review Substance Abuse

Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective

Natasha Yvonne Hall et al.

Summary: This study identified specific barriers to initiating opioid substitution therapy, including stigma, fear, regulatory, logistical, attitudinal, and social factors, with 19 barrier subthemes identified within these themes. The most reported barrier subthemes were negative treatment perceptions, cost, stigma, and lack of flexibility.

DRUG AND ALCOHOL DEPENDENCE (2021)

Letter Psychiatry

COVID-19 pandemic and addiction: Current problems in Iran

Bijan Pirnia et al.

ASIAN JOURNAL OF PSYCHIATRY (2020)

Review Psychology, Clinical

A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder

Katharine Cioe et al.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2020)

Review Psychiatry

Prevention and Treatment of Opioid Misuse and Addiction A Review

Nora D. Volkow et al.

JAMA PSYCHIATRY (2019)

Article Substance Abuse

Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation

Randi Sokol et al.

ADDICTION SCIENCE & CLINICAL PRACTICE (2019)

Review Substance Abuse

Treatment for opioid use and outcomes in older adults: a systematic literature review

Anne Marie Carew et al.

DRUG AND ALCOHOL DEPENDENCE (2018)

Article Public, Environmental & Occupational Health

Perceived barriers to methadone maintenance treatment among Iranian opioid users

Maryam Khazaee-Pool et al.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2018)

Review Toxicology

Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity

Michael S. Toce et al.

JOURNAL OF MEDICAL TOXICOLOGY (2018)

Review Psychology, Clinical

Developing an opioid use disorder treatment cascade: A review of quality measures

Arthur Robin Williams et al.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)

Review Psychology, Clinical

Group-based treatment of opioid use disorder with buprenorphine: A systematic review

Randi Sokol et al.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)

Review Medicine, General & Internal

Primary Care-Based Models for the Treatment of Opioid Use Disorder A Scoping Review

P. Todd Korthuis et al.

ANNALS OF INTERNAL MEDICINE (2017)

Article Psychiatry

Therapeutic Community Program for Opioid-Dependent Treatment Seekers

Zahra Alammehrjerdi et al.

IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES (2017)

Review Health Care Sciences & Services

Where Is the Evidence? A Systematic Review of Shared Decision Making and Patient Outcomes

L. Aubree Shay et al.

MEDICAL DECISION MAKING (2015)

Article Public, Environmental & Occupational Health

Improving Treatment for Opioid Dependence: A Perspective From the Ohio Valley Node of the NIDA Clinical Trials Network

Erin L. Winstanley et al.

PROGRESS IN COMMUNITY HEALTH PARTNERSHIPS-RESEARCH EDUCATION AND ACTION (2014)

Review Substance Abuse

Medication-assisted treatment for opioid use disorders in correctional settings: An ethics review

Ariel S. Ludwig et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2014)

Editorial Material Medicine, General & Internal

Shared Decision Making - The Pinnacle of Patient-Centered Care

Michael J. Barry et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Substance Abuse

Methadone Maintenance Therapy Outcomes in Iran

Roya Noori et al.

SUBSTANCE USE & MISUSE (2012)

Editorial Material Medicine, General & Internal

Patient-Centered Care and Preference-Sensitive Decision Making

Carla C. Keirns et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Psychology, Clinical

Buprenorphine maintenance treatment of heroin dependence: the first experience from Iran

J Ahmadi

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2002)